CompumedicsASX:CMP +2.00%61 Gross Margin % is 51.49% as of Dec. 2025, which is 3% below its 10-year median of 53.35. GuruFocus rates ASX:CMP with a GF Score™ of 61/100 and a GF Value™ of A$0.31 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Compumedics ranks better than 51.93% on this metric.
The historical rank and industry rank for Compumedics's Gross Margin % or its related term are showing as below:
ASX:CMP'
s Gross Margin % Range Over the Past 10 Years
Min: 50.91 Med: 53.35 Max: 59.68
Current: 53.25
During the past 13 years, the highestGross Margin % of Compumedics was 59.68%. The lowest was 50.91%. And the median was 53.35%.
ASX:CMP's Gross Margin % is ranked better than 51.93% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs ASX:CMP: 53.25
Compumedics had a gross margin of 51.49% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Compumedics was 0.80% per year.
Compumedics (ASX:CMP) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Compumedics had a gross margin of 51.49% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Compumedics Gross Margin % Related Terms
Compumedics Gross Margin % Historical Data
* Premium members only.
The historical data trend for Compumedics's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:CMP vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Compumedics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Compumedics Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Compumedics's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Compumedics's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Compumedics (ASX:CMP) has a Gross Margin % of 51.49% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Compumedics and its competitors. This is near median its historical median of 53.35. Over the past decade, Compumedics' Gross Margin % has ranged from 50.91 to 59.68. According to the industry distribution chart, Compumedics ranks #387 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 48.1%.
Is Compumedics' Gross Margin % too high?
Compumedics' current Gross Margin % of 51.49% is near median its 10-year median of 53.35. Over the past 10 years, this metric has ranged from a low of 50.91 to a high of 59.68. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Compumedics' value of 51.49% is 1.1% below this industry median. Based on the distribution chart, Compumedics ranks #387 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Compumedics has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Compumedics' Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Compumedics ranks #387 out of 805 companies for Gross Margin %. This puts Compumedics in the upper half of its industry. The industry median Gross Margin % is 52.07. Compumedics' value of 51.49% is 1.1% below this benchmark. Historically, Compumedics' own Gross Margin % has ranged from 50.91 to 59.68 over the past decade. While the company's 10-year median is 53.35 vs. the industry median of 52.07, Compumedics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Compumedics's current Gross Margin % of 51.49% is 1.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Compumedics and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Compumedics's current Gross Margin % is 51.49%, which is near median its own 10-year median of 53.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compumedics stock overvalued right now?
Based on GuruFocus' analysis, Compumedics (ASX:CMP) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.31, compared to a current price of A$0.26 — trading 17.7% below its estimated fair value. The current Gross Margin % is 51.49%, which is near median its 10-year median of 53.35 and 1.1% below the Medical Devices & Instruments industry median of 52.07. Compumedics' overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Compumedics (ASX:CMP), the current Gross Margin % is 51.49% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Compumedics (ASX:CMP) Overvalued in 2026?
Based on GuruFocus' analysis, Compumedics stock appears to be undervalued.
The current stock price of A$0.26 is trading 17.7% below its estimated GF Value™ of A$0.31.
GuruFocus considers Compumedics to be Modestly Undervalued.
Key valuation signals for ASX:CMP:
Gross Margin %: 51.49% (near median its 10-year median of 53.35)
GF Value™: A$0.31 vs. price of A$0.26 (17.7% below fair value)
Industry Position: 1.1% below the Medical Devices & Instruments median (#387 of 805)
No single metric tells the full story. See the ASX:CMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Compumedics Ltd is a medical device company. It is engaged in the development, manufacturing, and commercialization of diagnostic technologies for sleep, brain, and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
61GF Score
Get the complete analysis for ASX:CMP
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CMP has been successfully added to your 
